Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Jan 15, 2025; 17(1): 100210
Published online Jan 15, 2025. doi: 10.4251/wjgo.v17.i1.100210
Published online Jan 15, 2025. doi: 10.4251/wjgo.v17.i1.100210
Ref. | Country | Gender | Age | Primary symptoms | Radiologic or ultrasonic findings | Stage of syphilis | HIV infection | Treatment | Outcome |
Maincent et al[5], 1997 | France | Female | 56 | Right upper quadrant abdominal pain | Several low-density nodules with no contrast uptake | III | No | Penicillin G (daily for five days and weekly for six weeks) | The abdominal pain subsided, and the liver nodules disappeared |
Peeters et al[13], 2005 | / | Female | 47 | Vision problems, pain in the right hypochondrium, one enlarged submandibular lymph node | Two hepatic lesions | III | No | Doxycyclin | The sedimentation rate and liver tests normalized, and the hepatic lesions disappeared. However, vision problems remained |
Mahto et al[6], 2006 | United Kingdom | Male | 44 | Fever, severe persistent upper abdominal pain, weight loss, and a desquamating rash on the palms and soles | Mildly enlarged liver with multiple ill-defined hypoechoic lesions | II | Yes | Doxycycline twice daily for a month | Repeat CT at one month showed that the largest mass decreased in size, and at two months, there was near-complete resolution of the liver masses |
Shim[7], 2010 | South Korea | Female | 65 | Intermittent abdominal pain and distension | Ascites and two hepatic nodules with peripheral enhancement | III | No | In the beginning, platinumbased combination chemotherapy for six months; after recurrence, penicillin was used | Complete response after six cycles of chemotherapy but recurrence after nine months; liver nodules disappeared followed by penicillin application |
Hagen et al[3], 2014 | United States | Male | 51 | Follow-up with liver lesions during chemotherapy for Burkitt lymphoma | Two liver lesions on PET | I | Yes | Penicillin G for 2-3 weeks | Resolution of liver test abnormalities and 50% reduction of the liver masses size |
Male | 53 | Right upper quadrant abdominal pain and weight loss | Multiple enhancing lesions in the liver and spleen, up to 5.7 cm | I | Yes | Liver tests resolved, but follow-up imaging was not performed | |||
Male | 47 | Fatigue, left lower chest wall pain, fever, chills, intermittent diarrhea, and nausea | Over 50 enhancing lesions in the liver, the largest measuring 2.6 cm | I | Yes | The liver test abnormalities resolved, and virtually complete resolution of the hepatic lesions was achieved | |||
Gaslightwala et al[11], 2014 | United States | Male | 59 | Persistent fevers, chills, night sweats, and weight loss | Multiple intensely hypermetabolic hepatic lesions on PET/CT | III | No | Penicillin G | None |
Desilets et al[14], 2019 | Canada | Male | 54 | General deterioration, posterior rib pain, progressive weight loss | PET-scan showed multiple hypermetabolic liver nodules | II | Yes | Penicillin G | Complete interval resolution of hypermetabolic osteomedullary and liver lesions |
Al Dallal et al[15], 2021 | United States | Female | 36 | Unresponsive with convulsions of all extremities and fever | Multiple hypoenhancing lesions | III | No | Penicillin G for only four days due to patient refusal | Liver function improved, but follow-up imaging was not performed |
Smith et al[16], 2022 | Australia | Male | 39 | Right upper quadrant and several weeks of fluctuating tenesmus and diarrhea | Short segmental, irregular rectal wall thickening, bilateral mesorectal lymphadenopathy, and multiple hypoattenuating liver lesions | III | Yes | Penicillin G | Significant reduction in the size of a dominant lesion in the right anterior liver section, with no other appreciable lesions |
Otsuka et al[8], 2023 | Japan | Female | 50 | Low-grade fever and nausea | Three nodules in the S3, S4, and S5 of the liver with round ring enhancement at the portal phase | III | No | Sulbactam sodium and ampicillin sodium | Marked downsizing of liver nodules |
- Citation: Wang YJ, Liu ZC, Wang J, Yang YM. Multiple liver metastases of unknown origin: A case report. World J Gastrointest Oncol 2025; 17(1): 100210
- URL: https://www.wjgnet.com/1948-5204/full/v17/i1/100210.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i1.100210